FDA Seeks Public Assessments of Next-Gen Sequencing, Bioinformatics Tools | GenomeWeb

NEW YORK (GenomeWeb News) — The US Food and Drug Administration wants to find out what the scientific community thinks about how well the latest next-generation sequencing technologies perform, and to assess the pros and cons of these technologies and the new bioinformatics tools that are designed to work with them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.